Yehia Hashad - 08 Mar 2025 Form 4 Insider Report for Unity Biotechnology, Inc. (UBX)

Role: Director
Signature: /s/ Alexander Nguyen, Attorney-in-Fact for Yehia Hashad
Issuer symbol: UBX
Transactions as of: 08 Mar 2025
Transactions value $: $0
Form type: 4
Filing time: 10 Mar 2025, 08:03:04 UTC
Previous filing: 28 Feb 2025
Next filing: 28 Jul 2025
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	UBX	Stock Option (Right to Buy)	Award	$0	+20K		$0.00	20K	08 Mar 2025	Common Stock	20K	$1.68	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares subject to the stock option vest and become exercisable in successive, equal monthly installments over a 36-month period commencing on March 8, 2025 (the "Vesting Commencement Date"), so that 100% of the shares become fully vested and exercisable on the third anniversary of the Vesting Commencement Date, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Content

Shares subject to the stock option vest and become exercisable in successive, equal monthly installments over a 36-month period commencing on March 8, 2025 (the "Vesting Commencement Date"), so that 100% of the shares become fully vested and exercisable on the third anniversary of the Vesting Commencement Date, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.